Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey
Makoto Naganuma, Shinya Sugimoto, Hideo Suzuki, et al.
Journal of Gastroenterology (2019) Vol. 54, Iss. 10, pp. 891-896
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis
Akihito Yokote, Noriyuki Imazu, Junji Umeno, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 9, pp. 868-882
Closed Access | Times Cited: 25
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial
Shomron Ben‐Horin, Nir Salomon, G Karampekos, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 2, pp. 347-356.e6
Closed Access | Times Cited: 24
A Comprehensive Review of the Chemistry, Pharmacokinetics, Pharmacology, Clinical Applications, Adverse Events, and Quality Control of Indigo Naturalis
Quan Sun, Jing Leng, Ling Tang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 47
Comparison of indirubin concentrations in indigo naturalis ointment for psoriasis treatment: a randomized, double‐blind, dosage‐controlled trial
Yin‐Ku Lin, Lai‐Chu See, Yu‐Huei Huang, et al.
British Journal of Dermatology (2017) Vol. 178, Iss. 1, pp. 124-131
Closed Access | Times Cited: 60
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension
Takeshi Masaki, Makoto Okazawa, Ryotaro Asano, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 11
Open Access | Times Cited: 41
From natural dye to herbal medicine: a systematic review of chemical constituents, pharmacological effects and clinical applications of indigo naturalis
Qi-Yue Yang, Ting Zhang, Yanan He, et al.
Chinese Medicine (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 38
Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study
Henit Yanai, Nir Salomon, Adi Lahat, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 2, pp. 175-181
Open Access | Times Cited: 12
The double-edged sword effect of indigo naturalis
Yiqi Xu, Chengyuan Lin, Hor‐Yue Tan, et al.
Food and Chemical Toxicology (2024), pp. 114476-114476
Open Access | Times Cited: 4
Selected Use of Complementary and Alternative Medicine (CAM) Agents in IBD
Monica Dzwonkowski, Janak Bahirwani, Samantha Rollins, et al.
Current Gastroenterology Reports (2025) Vol. 27, Iss. 1
Closed Access
Pharmacokinetics of major indigo naturalis indole alkaloids in humans and their association with systemic aryl hydrocarbon receptor activity
Jeffry S. Tang, Alissa Cait, David O’Sullivan, et al.
Biochemical Pharmacology (2025) Vol. 235, pp. 116805-116805
Open Access
Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study
Makoto Naganuma, Shinya Sugimoto, T. Fukuda, et al.
Journal of Gastroenterology (2019) Vol. 55, Iss. 2, pp. 169-180
Closed Access | Times Cited: 28
Treatment-refractory ulcerative colitis responsive to indigo naturalis
Julie Saiki, Johan O. L. Andreasson, Kevin Grimes, et al.
BMJ Open Gastroenterology (2021) Vol. 8, Iss. 1, pp. e000813-e000813
Open Access | Times Cited: 23
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis
Fumie Shimada, Yusuke Yoshimatsu, Tomohisa Sujino, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial
Kan Uchiyama, Shinichiro Takami, Hideo Suzuki, et al.
PLoS ONE (2020) Vol. 15, Iss. 11, pp. e0241337-e0241337
Open Access | Times Cited: 23
Dramatically Improved Severe Pulmonary Arterial Hypertension Caused by Qing-Dai (Chinese Herbal Drug) for Ulcerative Colitis
Kana Kubota, Yasushi Imai, Takafumi Okuyama, et al.
International Heart Journal (2023) Vol. 64, Iss. 2, pp. 316-320
Open Access | Times Cited: 8
Development of an Indigo Naturalis Suppository for Topical Induction Therapy in Patients with Ulcerative Colitis
Yusuke Yoshimatsu, Makoto Naganuma, Shinya Sugimoto, et al.
Digestion (2019) Vol. 101, Iss. 4, pp. 492-498
Closed Access | Times Cited: 22
Clinical efficacy and future application of indigo naturalis in the treatment of ulcerative colitis
Dianzhen Wu, Qi Huang, Yingbi Xu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118782-118782
Closed Access | Times Cited: 2
One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective study
Yuichi Matsuno, Takehiro Torisu, Junji Umeno, et al.
Intestinal Research (2022) Vol. 20, Iss. 2, pp. 260-268
Open Access | Times Cited: 11
Development of pulmonary arterial hypertension following long-term Qing-Dai use for ulcerative colitis
Yuta Inoue, Atsushi Ishihara, Teruki Mori, et al.
Journal of Cardiology Cases (2023) Vol. 27, Iss. 5, pp. 218-221
Open Access | Times Cited: 6
Activation of the aryl hydrocarbon receptor inhibits the development of experimental autoimmune pancreatitis through IL-22-mediated signaling pathways
Ken Kamata, Akane Hara, Kosuke Minaga, et al.
Clinical & Experimental Immunology (2023) Vol. 212, Iss. 3, pp. 171-183
Open Access | Times Cited: 6
Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
Shomron Ben‐Horin, Uri Kopylov, Nir Salomon
Case Reports in Gastroenterology (2022) Vol. 16, Iss. 3, pp. 563-568
Open Access | Times Cited: 7
Indirubin mediates adverse intestinal reactions in guinea pigs by downregulating the expression of AchE through AhR
Xiaoting Xu, Reham Taha, Chenghan Chu, et al.
Xenobiotica (2024) Vol. 54, Iss. 2, pp. 83-94
Open Access | Times Cited: 1
Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis
Takahiro Hiraide, Toshiaki Teratani, Shizuka Uemura, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 3, pp. 385-388
Closed Access | Times Cited: 9
Qing‐Dai for pediatric ulcerative colitis multicenter survey and systematic review
Takahiro Kudo, Keisuke Jimbo, Hirotaka Shimizu, et al.
Pediatrics International (2021) Vol. 64, Iss. 1
Closed Access | Times Cited: 7
High-Quality Indigo Naturalis Obtained with Automatic Foam Separation
Xin Yang, Jun Tang, Juan Su, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 37, pp. 43272-43281
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top